Ebos moving management to Australia

ALAN WOOD
Last updated 05:00 25/02/2014

Relevant offers

Industries

Olympic swimmer Mark Weldon jumped in the deep end at MediaWorks Attention cat lovers: Ever wondered what your cat is trying to say? Kogan-run Dick Smith website hits the internet as stores close Australian budget could mean Kiwis less likely to report to Aussies Pressure on water bottlers to pay up Protestors rally in Auckland against ANZ's investment in fossil fuels Heat on Maori Television chief executive Paora Maxwell over staff turnover NZ unemployment jumps to 5.7 per cent despite strong job growth Mark Weldon right to resign from MediaWorks, former TV3 news boss says OIO faces 'independent review' following Onetai farm sale

Ebos Group's top operational management team will be based in Melbourne from late August, with Christchurch losing its head office status.

Managing director and chief executive Mark Waller will pass his chief executive role to Patrick Davies in August and the chief financial officer role will pass on to John Cullity about the same time, with Dennis Doherty retiring from the Christchurch office.

"The CEO and CFO need to sit together, and they will in Melbourne," Waller said after the company released its results last week.

He acknowledged that the two roles being based across the Tasman reflected an Australian growth strategy, though Christchurch would retain some of the power base.

"We've got large businesses in Sydney, large businesses in Melbourne, many large businesses in Auckland. The key executives for those businesses stay where they are. The corporate office - finance functions M&A [mergers and acquisitions] and strategy - will be split between Christchurch and Melbourne."

Davies is chief executive of Ebos-owned Symbion, and he and Cullity are already based in Melbourne.

"We've got such a chunk of our business in Australia now we felt that the operational side . . . really had to have a major Australian presence. Patrick Davies will pick up that role at the end of August."

Symbion, an Australian pharmaceutical wholesaler and distributor, bought by the NZX-listed Ebos last year. The $1.1 billion deal to buy Symbion from Hong Kong-based Zuellig Group brought in Zuellig as a 40 per cent shareholder.

Waller said the Zuellig family had "no input" into the succession plan.

Ad Feedback

- BusinessDay

Special offers

Featured Promotions

Sponsored Content